Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls

Table 4

Correlations of MMPs and their inhibitors with clinical oral parameters in the course of JIA in the sample population.

Salivary parameters		JIA						C
		DMFT	D	OHI-S	GI	PBI	SF	DMFT	D	OHI-S	GI	PBI	SF
MMP-2	r	0.11	0.005	0.36	0.28	0.26	−0.37	0.08	0.2	−0.12	0.14	0.12	−0.10
	p	0.538	0.97	0.036	0.109	0.139	0.033	0.641	0.26	0.485	0.440	0.488	0.576
MMP-8	r	0.16	0.14	0.21	0.26	0.26	−0.22	0.11	0.19	−0.04	0.19	0.19	0.18
	p	0.353	0.416	0.242	0.134	0.143	0.209	0.522	0.29	0.826	0.275	0.284	0.318
MMP-9	r	0.26	0.14	0.13	0.39	0.20	−0.13	−0.15	0.05	−0.24	−0.15	−0.13	−0.22
	p	0.133	0.421	0.48	0.021	0.257	0.461	0.404	0.78	0.177	0.398	0.461	0.206
TIMP-1	r	0.15	−0.02	−0.01	0.38	0.30	−0.30	0.08	0.24	−0.17	−0.01	−0.05	−0.26
	p	0.405	0.9	0.94	0.027	0.080	0.088	0.669	0.17	0.334	0.940	0.759	0.136
TIMP2	r	0.15	−0.04	0.09	0.29	0.20	−0.31	−0.15	0.12	−0.31	−0.16	−0.04	−0.25
	p	0.402	0.8	0.6	0.092	0.248	0.076	0.406	0.5	0.079	0.375	0.823	0.155

Note. Spearman’s rank correlation; statistically significant.